218 related articles for article (PubMed ID: 3235967)
21. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
[TBL] [Abstract][Full Text] [Related]
22. [A case report of thyroid papillary cancer that manifested leukocytosis and hypercalcemia after radiotherapy in bone metastasis].
Kobayashi H; Endo K; Nishimura K; Kasagi K; Yamamoto I; Konishi J; Abe M; Shimizu Y
Gan No Rinsho; 1989 Jan; 35(1):55-62. PubMed ID: 2646465
[TBL] [Abstract][Full Text] [Related]
23. [Usefulness of T1-201 chloride and NaI-131 scintigraphy in detection of metastasis from thyroid carcinoma].
Kusakabe K; Inoue Y; Kawasaki Y; Maki M; Nara S; Kondo C; Nishioka T; Hiroe M; Shigeta A; Kurihara S
Kaku Igaku; 1984 Aug; 21(8):941-51. PubMed ID: 6513192
[No Abstract] [Full Text] [Related]
24. [Radioiodine therapy for lung and bone metastasis of differentiated thyroid cancer].
Inagaki T; Shibata T; Iida Y; Kasagi K; Endo K; Konishi J; Torizuka K
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Mar; 45(3):518-24. PubMed ID: 4011426
[No Abstract] [Full Text] [Related]
25. Radioiodine therapy for differentiated thyroid carcinoma.
Connor CS; Thomas JH; Robinson RG; Preston DF; Hermreck AS
Am J Surg; 1988 Dec; 156(6):519-21. PubMed ID: 3202264
[TBL] [Abstract][Full Text] [Related]
26. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
[TBL] [Abstract][Full Text] [Related]
27. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
Campbell CM; Khafagi FA
Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
[TBL] [Abstract][Full Text] [Related]
28. Scintigraphy with 201Tl for detection of thyroid cancer metastases.
Piers DA; Sluiter WJ; Willemse PH; Doorenbos H
Eur J Nucl Med; 1982; 7(11):515-7. PubMed ID: 7173250
[TBL] [Abstract][Full Text] [Related]
29. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
Rudavsky AZ; Freeman LM
J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
[No Abstract] [Full Text] [Related]
30. [Distant metastasis of differentiated thyroid cancers. Diagnosis by 131 iodine (I 131) and treatment].
Leger AF
Ann Endocrinol (Paris); 1995; 56(3):205-8. PubMed ID: 7677405
[TBL] [Abstract][Full Text] [Related]
31. 131I dosimetry and thyroid stunning.
Gerard SK; Park HM
J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
[No Abstract] [Full Text] [Related]
32. Metastatic differentiated carcinoma of the thyroid and radioiodine.
Andrews JT; McGennisken MR
Australas Radiol; 1987 Feb; 31(1):41-6. PubMed ID: 3619809
[No Abstract] [Full Text] [Related]
33. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
[TBL] [Abstract][Full Text] [Related]
34. [Iodine scintigraphy of differentiated thyroid carcinoma].
Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
[No Abstract] [Full Text] [Related]
35. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
36. [Determining the activities of 131I with dose-rate constraint method for the treatment of differentiated thyroid carcinoma with diffuse pulmonary metastases].
Liu B; Zeng Y; Wang JT; Zhao Z; Mu D; Kuang AR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):513-7. PubMed ID: 20629335
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
Leung SF; Law MW; Ho SK
Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
[TBL] [Abstract][Full Text] [Related]
38. [Radionuclide therapy of thyroid disease--radioactive iodine therapy].
Kusakabe K; Maki M
Kaku Igaku; 1993 Jul; 30(7):813-9. PubMed ID: 8377305
[TBL] [Abstract][Full Text] [Related]
39. Aggressive poorly differentiated adenocarcinoma of the lung diagnosed 13 months after initial diagnosis of papillary thyroid carcinoma with "non-iodine concentrating" pulmonary metastasis.
Basu S; Rekhi B; Shamim SA; Jambhekar NA
Hell J Nucl Med; 2012; 15(3):252-3. PubMed ID: 23227462
[No Abstract] [Full Text] [Related]
40. Iodine-131 uptake in inflammatory lung disease: a potential pitfall in treatment of thyroid carcinoma.
Höschl R; Choy DH; Gandevia B
J Nucl Med; 1988 May; 29(5):701-6. PubMed ID: 3373306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
